ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,840Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 2588

$1.35M Total Retail Price of All Prescriptions

Rank: 37 out of 2588

556 Patients Receiving at Least One Drug in Part D
53%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 556 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

21% of this provider’s 556 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 12,348 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 1,007 526 1 1
LISINOPRIL 878 562 2 3
FUROSEMIDE 683 411 3 5
LEVOTHYROXINE SODIUM 670 347 4 2
OMEPRAZOLE 636 285 5 6
HYDROCODONE-ACETAMINOPHEN 623 266 S3 6 7
METOPROLOL TARTRATE 532 293 7 9
FAMOTIDINE 494 255 8 36
POTASSIUM CHLORIDE 491 219 9 15
AMLODIPINE BESYLATE 464 224 10 4
TRAMADOL HCL 436 216 11 19
WARFARIN SODIUM 406 293 12 10
METFORMIN HCL 362 188 13 8
TAMSULOSIN HCL 295 223 14 23
GABAPENTIN 280 133 15 18
PANTOPRAZOLE SODIUM 280 185 15 28
DIVALPROEX SODIUM 277 78 17 89
METOPROLOL SUCCINATE 255 158 18 12
PAROXETINE HCL 248 158 19 71
NAMENDA 248 195 19 32
LANTUS 237 120 21 47
CLOPIDOGREL 228 153 22 30
IBUPROFEN 226 39 23 62
CLONIDINE HCL 223 85 24 54
PROAIR HFA 220 78 25 50
CARVEDILOL 213 129 26 20
GLIPIZIDE 212 128 27 44
ADVAIR DISKUS 209 113 28 48
DONEPEZIL HCL 207 168 29 22
RISPERIDONE 203 87 30 57
DIGOXIN 193 143 31 38
ATORVASTATIN CALCIUM 190 123 32 11
CYCLOBENZAPRINE HCL 189 42 R 33 87
ALLOPURINOL 184 116 34 33
PLAVIX 179 125 35 43
HYDROCHLOROTHIAZIDE 169 100 36 13
GEMFIBROZIL 167 48 37 123
SERTRALINE HCL 160 112 38 26
VENTOLIN HFA 155 39 39 101
RANITIDINE HCL 153 29 40 37
LACTULOSE 150 91 41 135
CRESTOR 144 93 42 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 143 84 43 35
LOSARTAN POTASSIUM 142 119 44 17
NAPROXEN 141 38 45 95
PHENYTOIN SODIUM EXTENDED 139 72 46 109
BENZTROPINE MESYLATE 138 12 R 47 107
SINGULAIR 132 53 48 94
PREDNISONE 130 90 49 42
CYMBALTA 124 32 50 70
ALENDRONATE SODIUM 120 95 51 21
CIPROFLOXACIN HCL 119 70 52 82
FLUTICASONE PROPIONATE 119 41 52 40
DIVALPROEX SODIUM ER 112 0 54 121
KLOR-CON M20 111 81 55 52
JANUVIA 109 83 56 60
OXYBUTYNIN CHLORIDE 109 23 56 132
MIRTAZAPINE 106 79 58 63
OXYBUTYNIN CHLORIDE ER 105 60 59 85
NIASPAN 103 56 60 115
SPIRIVA 97 65 61 56
ESCITALOPRAM OXALATE 95 74 62 68
TRICOR 94 51 63 122
HYDRALAZINE HCL 92 69 64 53
TRAZODONE HCL 91 44 65 61
INSULIN SYRINGE 88 43 66 81
AZITHROMYCIN 87 40 67 45
METOCLOPRAMIDE HCL 84 24 68 136
ENALAPRIL MALEATE 84 19 68 31
ZOLPIDEM TARTRATE 84 47 68 24
VALPROIC ACID 79 0 71 174
FINASTERIDE 79 79 71 97
LEVOFLOXACIN 78 40 73 77
MONTELUKAST SODIUM 77 28 74 153
DILTIAZEM 24HR CD 76 67 75 98
NITROGLYCERIN PATCH 75 42 76 149
SPIRONOLACTONE 75 41 76 58
AMIODARONE HCL 73 54 78 156
NOVOLIN R 68 36 79 175
CITALOPRAM HBR 67 38 80 27
LEVETIRACETAM 67 14 80 90
LOVAZA 66 0 82 119
LYRICA 66 20 82 100
VENLAFAXINE HCL ER 65 40 84 125
SURE COMFORT 64 27 85 227
TOPIRAMATE 64 22 85 167
ISOSORBIDE MONONITRATE ER 63 62 87 49
CARBIDOPA-LEVODOPA 63 63 87 83
NOVOLIN N 63 21 87 298
NEXIUM 63 24 87 41
FENTANYL 62 22 S2 91 78
ATENOLOL 60 45 92 14
GLYBURIDE 60 39 R 92 65
PRIMIDONE 60 25 92 363
ACETAMINOPHEN-CODEINE 60 17 S3 92 80
KLOR-CON M10 59 45 96 139
BETAMETHASONE VALERATE 58 19 97 360
CALCITRIOL 58 45 97 210
BYSTOLIC 57 44 99 110
ZETIA 56 27 100 69
NIFEDIPINE ER 56 18 100 59
ALBUTEROL SULFATE 55 22 102 116
THEOPHYLLINE ANHYDROUS 55 19 102 253
VESICARE 54 12 104 172
SYMBICORT 53 0 105 129
LANTUS SOLOSTAR 52 24 106 93
ROPINIROLE HCL 52 23 106 113
LEXAPRO 52 28 106 182
AMOX TR-POTASSIUM CLAVULANATE 52 33 106 131
TRILIPIX 52 0 106 185
NOVOLOG 51 22 111 103
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 23, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.